UK markets closed

Genmab A/S (0MGB.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
2,581.26-9.88 (-0.38%)
At close: 06:18PM BST
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 37.50%
S&P500 52-week change 326.14%
52-week high 33,325.00
52-week low 32,379.00
50-day moving average 32,623.67
200-day moving average 32,718.21

Share statistics

Avg vol (3-month) 314.98k
Avg vol (10-day) 316.26k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 864.48M
% held by insiders 10.01%
% held by institutions 147.45%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 30.74%
Operating margin (ttm)19.33%

Management effectiveness

Return on assets (ttm)10.63%
Return on equity (ttm)18.32%

Income statement

Revenue (ttm)17.78B
Revenue per share (ttm)272.41
Quarterly revenue growth (yoy)45.20%
Gross profit (ttm)N/A
EBITDA 5.95B
Net income avi to common (ttm)5.47B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)486.30%

Balance sheet

Total cash (mrq)29.58B
Total cash per share (mrq)454.15
Total debt (mrq)1.01B
Total debt/equity (mrq)3.11%
Current ratio (mrq)12.46
Book value per share (mrq)498.87

Cash flow statement

Operating cash flow (ttm)5.66B
Levered free cash flow (ttm)3.83B